Overview

An Open Label Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing in Human Subjects

Status:
Completed

Trial end date:
2011-02-01

Target enrollment:

Participant gender:

Summary

This is an open label study. The study will consist of 1 treatment group: coated Nifedipine suppository containing 12 mg of Nifedipine, administered BID to subjects with chronic anal fissure.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

RDD Pharma Ltd

Treatments:

Nifedipine